APA (7th ed.) Citation

T, D., D, S., C, D., D, M., C, K., M, G., . . . H, B. (2020). Thromboprophylaxis in COVID-19: Anti-FXa-the Missing Factor? American journal of respiratory and critical care medicine, 202(3), 455. https://doi.org/10.1164/rccm.202005-1654LE

Chicago Style (17th ed.) Citation

T, Dutt, Simcox D, Downey C, McLenaghan D, King C, Gautam M, Lane S, and Burhan H. "Thromboprophylaxis in COVID-19: Anti-FXa-the Missing Factor?" American Journal of Respiratory and Critical Care Medicine 202, no. 3 (2020): 455. https://doi.org/10.1164/rccm.202005-1654LE.

MLA (9th ed.) Citation

T, Dutt, et al. "Thromboprophylaxis in COVID-19: Anti-FXa-the Missing Factor?" American Journal of Respiratory and Critical Care Medicine, vol. 202, no. 3, 2020, p. 455, https://doi.org/10.1164/rccm.202005-1654LE.